Markets:

Overview

News

Currencies

International

Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

3.285 +0.185 (+5.97%)

Streaming Delayed Price Updated: 2:30 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

38 39 Next >

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc.(SAVA) Shareholders

December 16, 2024

Via ACCESSWIRE

Contact Levi & Korsinsky by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc. (SAVA)

December 16, 2024

Via ACCESSWIRE

Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky About Pending Class Action - SAVA

December 16, 2024

Via ACCESSWIRE

Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 - SAVA

December 16, 2024

Via ACCESSWIRE

CASSAVA SCIENCES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA

December 15, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Unpacking the Latest Options Trading Trends in Cassava Sciences ↗

November 26, 2024

Via Benzinga

Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA

December 15, 2024

Via ACCESSWIRE

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

December 15, 2024

Via ACCESSWIRE

Shareholders of Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA

December 15, 2024

Via ACCESSWIRE

February 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SAVA

December 14, 2024

Via ACCESSWIRE

Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky about Pending Class Action - SAVA

December 13, 2024

Via ACCESSWIRE

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA

December 13, 2024

Via ACCESSWIRE

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

December 13, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAVA

December 13, 2024

Via ACCESSWIRE

SAVA LAWSUIT ALERT: Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

December 13, 2024

Via ACCESSWIRE

Top Biotech Short Squeeze Stocks ↗

December 12, 2024

Investing in biotechnology stocks offers a unique opportunity for individuals looking to gain exposure to one of the most dynamic and innovative sectors of the market.

Via Talk Markets

Topics Stocks / Equities

10 Health Care Stocks Whale Activity In Today's Session ↗

December 04, 2024

Via Benzinga

S&P 500, Nasdaq Hit Record Highs To Start December ↗

December 02, 2024

Stocks are a mixed bag this afternoon, with the S&P 500 Index and Nasdaq Composite earlier touching fresh record highs as the latter jumps triple digits.

Via Talk Markets

Topics Stocks Stocks / Equities

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 02, 2024

Via Benzinga

Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership ↗

November 30, 2024

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Via Benzinga

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 26, 2024

Via Benzinga

Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

November 25, 2024

SAVA, ZM, KSS, RIVN, TSLA were among the trending stocks among investors on Monday Nov. 25, 2024.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 25, 2024

Via Benzinga

Gold Down Over 3%; Rigetti Computing Shares Spike Higher ↗

November 25, 2024

Via Benzinga

Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October ↗

November 25, 2024

Via Benzinga

Topics Economy

'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update ↗

November 25, 2024

Pharma bro Martin Shkreli predicted Cassava Sciences stock would fall and the company would miss primary endpoints for its Phase 3 trial.

Via Benzinga

Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings ↗

November 25, 2024

Via Benzinga

Topics Stocks

Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies ↗

November 25, 2024

Cassava Sciences' stock fell after Phase 3 simufilam trial failed to meet key endpoints, prompting the discontinuation of its Alzheimer's studies.

Via Benzinga

Cassava Sciences Plummets 85% After Embattled Alzheimer's Drug Flops ↗

November 25, 2024

The company tested simufilam in patients with mild-to-moderate Alzheimer's disease.

Via Investor's Business Daily

Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 25, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.